Skip to the page

Data / Form D filings / TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc.: Form D filings

TriSalus Life Sciences, Inc., a health care company in Westminster, CO, filed 8 Form D notices with the SEC between 2011 and 2022. The latest, on November 10, 2022, reports $15.3 million sold of a $42.1 million offering to 32 investors.

Find out what TriSalus Life Sciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
6272 WEST 91ST AVENUE, Westminster, CO, 80031
Phone
(415) 336-8917
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Colorado
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1518906

The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 10, 2022New notice$42,142,857$15,321,429$26,821,42832Oct 5, 2022sec.gov
Nov 10, 2022New notice$23,500,000$23,500,000$04Sep 29, 2021sec.gov
Nov 10, 2022New notice$81,391,914$81,391,914$057Mar 18, 2021sec.gov
Mar 7, 2017New notice$15,000,000$12,858,752$2,141,24819Feb 24, 2017sec.gov
Nov 5, 2015Amendment$15,047,357$15,047,357$054Jun 12, 2015sec.gov
Jun 23, 2015New notice$14,053,711$11,047,356$3,006,35554Jun 12, 2015sec.gov
Sep 16, 2013New notice$21,328,000$16,419,987$4,908,01330Sep 10, 2013sec.gov
Apr 26, 2011New notice$6,732,000$3,694,524$3,037,47642Apr 20, 2011sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Simone SongDirector
Mary T. SzelaExecutive Officer, Director
John L. TullisDirector
Diane ParksDirector
Sean MurphyExecutive Officer, Director
Mats L. WahlstromDirector
Kerry HicksDirector
Gene McGrevinDirector
Anil SinghalDirector

Other health care companies in Colorado that filed recently

Every Form D from the week of Nov 7, 2022 · All recent filings in Colorado · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what TriSalus Life Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.